Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week [Yahoo! Finance]
Syros Pharmaceuticals, Inc. (SYRS)
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.syros.com
Company Research
Source: Yahoo! Finance
The top 7 shareholders own 51% of the company Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock Every investor in Syros Pharmaceuticals, Inc. ( NASDAQ:SYRS ) should be aware of the most powerful shareholder groups. With 32% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk). Last week's 17% gain means that institutional investors were on the positive end of the spectrum even as the company has shown strong longer-term trends. The one-year return on investment is currently 89% and last week's gain would have been more than welcomed. In the chart below, we zoom in on the different ownership groups of Syros Pharmaceuticals. Check out our latest analysis for Syros Pharmaceuticals What Does The Institutional Ownership Tell Us About Syros Pharmaceuticals? Institutions typically measure themselves against a benchmark when
Show less
Read more
Impact Snapshot
Event Time:
SYRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SYRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SYRS alerts
High impacting Syros Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SYRS
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRSAccesswire
- Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Investors Are Urged To Assist The Schall Law FirmAccesswire
- The Schall Law Firm Invites Shareholders To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Violating Securities Laws Accesswire
- CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syros Pharmaceuticals, Inc. - SYRSPR Newswire
SYRS
Earnings
- 7/31/24 - Beat
SYRS
Analyst Actions
- 8/1/24 - HC Wainwright
SYRS
Sec Filings
- 9/18/24 - Form 4
- 9/18/24 - Form 4
- 9/12/24 - Form 4
- SYRS's page on the SEC website